Category: Laser/Light-based DevicesSyndicate content

Invuity registers for $69M IPO

April 27, 2015 by Brad Perriello

Advanced surgical lighting maker Invuity registers for an initial public offering worth $69 million.

Invuity registers for $69M IPO

Invuity this month filed registration papers for an initial public offering that could bring in as much as $69 million for the advanced surgical lighting maker.

San Francisco-based Invuity said it plans to list on the NASDAQ exchange under the "IVTY" symbol.

RayVio exits stealth mode with $9.3m Series B

March 11, 2015 by Val Kennedy

RayVio raises a $9.3 million Series B round for its UV LED technology, which it says can potentially be used in a handheld device.

RayVio exits stealth mode with $9.3m Series B

RayVio emerged from stealth mode with a $9.3 million Series B round it plans to use on developing its UV LED technology.

Participants in the round included new investors Applied Ventures, Augment Ventures, New Ground Ventures and Tolero Ventures. Existing backers DCM Ventures and Capricorn Investment Group also participated.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser

November 13, 2014 by Brad Perriello

Monteris Medical says it's drummed up a $30 million Series B round for its NeuroBlate laser robotic surgery platform.

Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser

Monteris Medical said a pair of new backers joined a $30 million Series B round it plans to use to expand the commercial footprint of its NeuroBlate robotic brain tumor laser.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase lands $35m private placement

November 11, 2014 by Val Kennedy

Dental laser maker Biolase lands a $35 million private placement with a group of investors that includes its chairman, chief executive officer and top stockholders.

Biolase lands $35m private placement

Dental laser maker Biolase (NSDQ:BIOL) said in landed a $35 million private placement with a group of investors that includes its chairman, CEO and top stockholders.

FDA studies show nearly half of LASIK patients report problems

October 21, 2014 by Brad Perriello

Nearly half of the patients who underwent LASIK laser eye surgery reported problems after the procedure, according to an FDA study, although only 1% said the problems interfered with their daily lives.

FDA: Studies show nearly half of LASIK patients report problems

Some 45% of patients who had a laser eye surgery called LASIK later reported at least 1 visual symptom 3 months after the procedure, the FDA said yesterday.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cynosure drops $13.2M on Ellman's RF devices

September 8, 2014 by Arezu Sarvestani

Cynosure rounds out its minimally and non-invasive aesthetics portfolio with the $13.2 million acquisition of Ellman Intl. and its radiofrequency devices.

Cynosure drops $13.2M on Ellman's RF devices

Massachusetts-based Cynosure (NSDQ:CYNO) is looking to expand its market with new radiofrequency-based devices picked up in its $13.2 million acquisition of Ellman Intl.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase ex-CEO demands answers following his board resignation

August 14, 2014 by Arezu Sarvestani

Ousted CEO Federico Pignatelli turns the spotlight on new leadership at his former company after resigning from the board of directors.

Biolase ex-CEO demands answers following his resignation

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn't ready to put down his dukes after dropping his seat on the company's board of directors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.